Further processing options
Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer
Saved in:
Journal Title: | Molecular Cancer Therapeutics |
---|---|
Authors and Corporations: | , , , , , , , , |
In: | Molecular Cancer Therapeutics, 17, 2018, 9, p. 1859-1870 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Association for Cancer Research (AACR)
|
Subjects: |